AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) bought $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Mar 2, 2017.
The trade happened on Feb 1, 2017, 29 days before it was made public.
BMY has moved +24.1% since the trade date, from $49.29 to $61.15 (Oct 2, 2026 close).
- Traded
- Feb 1, 2017
- Disclosed
- Mar 2, 2017
- Filing delay
- 29 days
- Price since
- +24.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (5)
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.